Currently, PD-1 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) are two well-characterized and extensively studied in the DLBCL tumor immune microenvironment (8). This evidence concerns the gene CTLA4 and diffuse large B-cell lymphoma.